Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has enclosed copies of newspaper advertisement of the financial results of the company for the first quarter ended June 30, 2024, as published in Business Standard and Nava Telangana on August 12, 2024.
The above information is a part of company’s filings submitted to BSE.